IRVINE, Calif., September 17, 2020 — Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the initiation of research coverage on Atossa Therapeutics, Inc. (NasdaqCM: ATOS) of Seattle, Washington. For a copy of the initiation report, please click here.